Sam Slutsky
Stock Analyst at LifeSci Capital
(4.97)
# 85
Out of 4,345 analysts
585
Total ratings
52.3%
Success rate
43.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $170 | $129.73 | +31.04% | 31 | May 27, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | $125 | $57.99 | +115.55% | 20 | May 23, 2026 | |
| IMVT Immunovant | Rated: Buy | $42 → $45 | $33.41 | +34.69% | 70 | May 23, 2026 | |
| PYXS Pyxis Oncology | Maintained: Buy | $6 | $1.73 | +246.82% | 20 | May 23, 2026 | |
| IMUX Immunic | Maintained: Buy | $56 | $14.00 | +300.00% | 4 | May 16, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $103 | $72.51 | +42.05% | 50 | May 16, 2026 | |
| ELVN Enliven Therapeutics | Maintained: Buy | $60 | $41.41 | +44.89% | 36 | May 16, 2026 | |
| ALXO ALX Oncology Holdings | Maintained: Hold | n/a | $1.96 | - | 28 | May 16, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $45 | $25.33 | +77.65% | 5 | May 16, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | $29 | $12.91 | +124.63% | 39 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $108 | $60.80 | +77.63% | 32 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $27.47 | +52.89% | 25 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22.09 | $9.92 | +122.71% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 → $67 | $31.65 | +111.69% | 39 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $222 → $225 | $116.26 | +93.53% | 23 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $34.51 | +59.37% | 50 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $4.13 | +287.41% | 12 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $1.09 | +450.46% | 20 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.56 | - | 30 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $18.50 | +148.65% | 11 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.16 | $2.46 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7.5 | $5.93 | n/a | 22 | Dec 27, 2022 |
ABIVAX Société Anonyme
May 27, 2026
Reiterated: Buy
Price Target: $170
Current: $129.73
Upside: +31.04%
Oruka Therapeutics
May 23, 2026
Maintained: Buy
Price Target: $125
Current: $57.99
Upside: +115.55%
Immunovant
May 23, 2026
Rated: Buy
Price Target: $42 → $45
Current: $33.41
Upside: +34.69%
Pyxis Oncology
May 23, 2026
Maintained: Buy
Price Target: $6
Current: $1.73
Upside: +246.82%
Immunic
May 16, 2026
Maintained: Buy
Price Target: $56
Current: $14.00
Upside: +300.00%
Spyre Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $103
Current: $72.51
Upside: +42.05%
Enliven Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $60
Current: $41.41
Upside: +44.89%
ALX Oncology Holdings
May 16, 2026
Maintained: Hold
Price Target: n/a
Current: $1.96
Upside: -
Damora Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $45
Current: $25.33
Upside: +77.65%
Olema Pharmaceuticals
May 16, 2026
Maintained: Buy
Price Target: $29
Current: $12.91
Upside: +124.63%
May 16, 2026
Maintained: Buy
Price Target: $108
Current: $60.80
Upside: +77.63%
May 16, 2026
Maintained: Buy
Price Target: $42
Current: $27.47
Upside: +52.89%
May 15, 2026
Maintained: Buy
Price Target: $22.09
Current: $9.92
Upside: +122.71%
May 9, 2026
Rated: Buy
Price Target: $70 → $67
Current: $31.65
Upside: +111.69%
May 9, 2026
Rated: Buy
Price Target: $222 → $225
Current: $116.26
Upside: +93.53%
May 9, 2026
Maintained: Buy
Price Target: $55
Current: $34.51
Upside: +59.37%
May 9, 2026
Maintained: Buy
Price Target: $16
Current: $4.13
Upside: +287.41%
May 9, 2026
Rated: Buy
Price Target: $6
Current: $1.09
Upside: +450.46%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $2.56
Upside: -
Apr 20, 2026
Maintained: Buy
Price Target: $46
Current: $18.50
Upside: +148.65%
Dec 14, 2023
Maintained: Hold
Price Target: $1.16
Current: $2.46
Upside: n/a
Dec 27, 2022
Rated: Buy
Price Target: $7.5
Current: $5.93
Upside: n/a